COMPANY

Capienda Biotech, LLC

HQ: San Diego, CA source · capienda.us ↗ · West Coast

Location: San Diego, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1.4M (SBIR Phase II 2R44TR005335-02A1, competing renewal, notice Sep 17, 2026). NIH RePORTER 2R44TR005335-02A1 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 2R44TR005335-02A1
  Organization: CAPIENDA BIOTECH, LLC; City/State: San Diego, CA; Project number: 2R44TR005335-02A1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 1401698; Administering IC: National Center for Advancing Translational Sciences; Project title: High-throughput kinetic system for small-molecule drug discovery; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 17, 2026 Grant Government grant — SBIR: $1.4M (annual award, as published), announced Sep 17, 2026. Agency: NIH/NCATS. Source: government award database. source ↗
Aug 1, 2025 Grant Government grant — SBIR: $329,272 (annual award, as published), announced Aug 1, 2025. Agency: NIH/NCATS. Source: government award database. source ↗

Last 2 years.

Sep 17, 2026 Government grant — SBIR: $1.4M (annual award, as published), announced Sep 17, 2026. Agency: NIH/NCATS. Source: government award database. source ↗
Aug 1, 2025 Government grant — SBIR: $329,272 (annual award, as published), announced Aug 1, 2025. Agency: NIH/NCATS. Source: government award database. source ↗